通过 Stapled Peptide PROTAC 来针对蛋白质激酶A 的降解
Matthew K Whittaker1, George N Bendzunas1, Mahsa Shirani2
1Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia 30602, United States.
ACS chemical biology
|August 13, 2024
概括
研究人员开发了一种新型的堆抑制剂-PROTAC (StIP-TAC) 来降解蛋白激酶A (PKA). 这种StIP-TAC通过E3酶招募有效降解PKA,扩大了PROTAC用于挑战蛋白质标的应用.
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
背景情况:
- 化向的仿真体 (PROTACs) 是双功能分子,通过招募E3无素连接酶来诱导向蛋白质降解.
- 目前的PROTACs通常依赖于小分子抑制剂,将其应用限制在具有适合小分子结合的结构特征的蛋白质上.
- 需要扩大用于PROTAC介导降解的可访问蛋白质标的范围.
研究的目的:
- 开发一种新型的PROTAC,使用碳化合物合化物作为向剂.
- 创建一个用于向降解蛋白激酶A (PKA) 的StIP-TAC.
- 评估StIP-TAC技术对蛋白质降解的有效性和范围.
主要方法:
- 设计和合成一个StIP-TAC分子,将碳化合物结合与E3结合酶结合体连接起来.
- 用StIP-TAC对细胞进行处理,以诱导PKA的降解.
- 使用蛋白质酶抑制剂MG-132评估PKA降解并测量PKA基质酸化.
主要成果:
- 开发的StIP-TAC成功诱导了PKA的E3介导降解.
- 在添加蛋白质体抑制剂MG-132后,降解效应是可逆的.
- 治疗StIP-TAC导致PKA基质酸化的显著降低.
结论:
- 拼接抑制-PROTACs (StIP-TACs) 在实现向蛋白质降解方面是有效的.
- 这种方法扩大了PROTAC技术的适用性,使其适用于不能接受小分子抑制的蛋白质标.
- 通过向性蛋白质降解,StIP-TACs代表了扩大可药性蛋白质组的有希望的策略.
相关概念视频
The Proteasome
8.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.6K
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K
The Proteasome Structure
718
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
718


